tradingkey.logo

Natural Alternatives International Inc

NAII
查看詳細走勢圖
3.220USD
+0.070+2.22%
收盤 12/19, 16:00美東報價延遲15分鐘
19.89M總市值
虧損本益比TTM

Natural Alternatives International Inc

3.220
+0.070+2.22%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+2.22%

5天

+2.22%

1月

+3.87%

6月

-2.72%

今年開始到現在

-25.29%

1年

-24.06%

查看詳細走勢圖

操作建議

Natural Alternatives International Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在藥品行業排名120/158位。機構持股佔比非常高,中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Natural Alternatives International Inc評分

相關信息

行業排名
120 / 158
全市場排名
360 / 4582
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Natural Alternatives International Inc亮點

亮點風險
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.
估值合理
公司最新PE估值-1.61,處於3年歷史合理位
機構減倉
最新機構持股2.06M股,環比減少4.12%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉291.86K股

Natural Alternatives International Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Natural Alternatives International Inc簡介

Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.
公司代碼NAII
公司Natural Alternatives International Inc
CEOLedoux (Mark A)
網址https://www.nai-online.com/

常見問題

Natural Alternatives International Inc(NAII)的當前股價是多少?

Natural Alternatives International Inc(NAII)的當前股價是 3.220。

Natural Alternatives International Inc 的股票代碼是什麼?

Natural Alternatives International Inc的股票代碼是NAII。

Natural Alternatives International Inc股票的52週最高點是多少?

Natural Alternatives International Inc股票的52週最高點是4.400。

Natural Alternatives International Inc股票的52週最低點是多少?

Natural Alternatives International Inc股票的52週最低點是2.570。

Natural Alternatives International Inc的市值是多少?

Natural Alternatives International Inc的市值是19.89M。

Natural Alternatives International Inc的淨利潤是多少?

Natural Alternatives International Inc的淨利潤為-13.57M。

現在Natural Alternatives International Inc(NAII)的股票是買入、持有還是賣出?

根據分析師評級,Natural Alternatives International Inc(NAII)的總體評級為--,目標價格為--。

Natural Alternatives International Inc(NAII)股票的每股收益(EPS TTM)是多少

Natural Alternatives International Inc(NAII)股票的每股收益(EPS TTM)是-1.996。
KeyAI